First-in-Human Trial Using BXQ-350 for the Treatment of Cancer
Bexion Pharmaceuticals Announces the Opening of Phase I Part 3 FOR IMMEDIATE RELEASE Covington, KY ~ February 22, 2019 - Bexion Pharmaceuticals, Inc. (Bexion) announced today the opening of Part 3 of their Phase I First-In-Human Trial using BXQ-350 for the treatment of cancer. This trial was designed to determine the maximum tolerated dose of BXQ-350 and to